LSBWFOTC

LakeShore Biopharma Co., Ltd.

Healthcare·Healthcare·Beijing, China

LakeShore Biopharma Co., Ltd. (LSBWF): 2 pipeline candidates. Updated within the last hour.

6.0/10

BioSniper Score

2-factor signal · derived from public data

Cash RunwayN/A

N/A

Financial Health7.4

D/E 1.74 · 0% dilution

Pipeline MaturityN/A

N/A

Pipeline Breadth4.6

2 candidates

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for LakeShore Biopharma Co., Ltd.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$6K

Cash

$15.0M

Quarterly Burn

—

Runway

—

Revenue

—

Pipeline (2 candidates)

DrugPhase
image star ii—
image star ii—
·CEO: Mr. Wang Xu

Frequently asked questions

How many drug candidates are in LakeShore Biopharma Co., Ltd.'s pipeline?

LakeShore Biopharma Co., Ltd. (LSBWF) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is LakeShore Biopharma Co., Ltd.'s market capitalization?

LakeShore Biopharma Co., Ltd.'s market capitalization is approximately $6K.

Who is the CEO of LakeShore Biopharma Co., Ltd.?

Mr. Wang Xu is the chief executive officer of LakeShore Biopharma Co., Ltd. (LSBWF).

Get the full picture on LakeShore Biopharma Co., Ltd.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.

Start Free AnalysisBrowse Calendar